IGLANBA
Live / Applied — New application — not yet assigned to an examiner (as of 12 Feb 2026)
What this means for you
Not registered yet, but its 12 Feb 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99649970
- Mark type
- Stylized text
- Filed
- 12 Feb 2026
- Attorney of record
- Eric R. Moran
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals; pharmaceutical preparations; pharmaceutical products; insulin; insulin glargine; insulin analog; anti-diabetics; pharmaceuticals for treating diabetes; pharmaceutical preparations for treating diabetes; pharmaceutical products for treating diabetes; pharmaceutical preparations, namely, injectable insulin; pharmaceutical preparations, namely, injectable insulin glargine; pharmaceutical preparations, namely, injectable insulin analog; pharmaceutical preparations, namely, injectable anti-diabetics; injectable pharmaceutical preparations for treating diabetes; injectable pharmaceutical products for treating diabetes; injectors sold filled with insulin; insulin injectors sold filled with insulin glargine; insulin injectors sold filled with insulin analog; injectors sold filled with pharmaceuticals for treating diabetes; injectors sold filled with anti-diabetics
Owner
- Emerge Bioscience Pte. Ltd., Singapore, SG
Prosecution history
- 12 Feb 2026 — APPLICATION FILING RECEIPT MAILED
- 12 Feb 2026 — NEW APPLICATION ENTERED